1
项与 Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.) 相关的临床试验Study of Anti-CD19 Chimeric Antigen Receptor T Cells(PZ01) for Relapsed/ Refractory B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma
The major aim of this research is to assess the feasibility, safety and effectiveness of CD19 CAR-T Cell Therapy for Relapsed/ Refractory Acute Lymphoblastic Leukemia/ B cell Lymphoma patients who have applied it.
100 项与 Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.) 相关的临床结果
100 项与 Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.) 相关的转化医学
100 项与 Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.) 相关的专利(医药)
100 项与 Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.) 相关的药物交易